Dear Members, IMDRF have issued Industry guidance on the considerations for the selection of IMDRF Adverse Event Terminology N86: Final 2026 It includes examples of which 8, 12 and 18 are specific to IVDs. Considerations for the selection of IMDRF Adverse Event Terminology – A Guide for Industry Partners and Healthcare Providers View article...
Ben KempMarch 5, 2026
Dear Members, please see below the legislative changes applicable to EU Corporate Sustainability reporting. Although these requirements impact which companies have reporting obligations, it is still worth considering that if you are a small company not required to report, but if you supply a larger organisation with reporting obligations, including Scope 3, you may still find yourself having to provide…
Ben KempMarch 5, 2026
Antimicrobial resistance threatens health across the human, animal, plant and environmental sectors. Diagnostics are essential to prevent infections, guide appropriate treatment and reduce unnecessary antimicrobial use. Significant gaps remain. As part of ARREST AMR's efforts to identify diagnostic needs across all One Health sectors, they invite you to participate in their Veterinary Sector Focus Group to help define the most…
Ben KempMarch 4, 2026
Taking place on 10 March 2026 1:00pm – 2:00pm. You can register here. Background The National Health Service (Procurement, Slavery and Human Trafficking) Regulations 2025 have been signed into law and will come into force on 17th May 2026. They require in-scope organisations to risk assess procurements for goods and service for the NHS and take reasonable steps to address and where possible…
Ben KempMarch 4, 2026
UK research projects get long-awaited access to consenting participants’ GP data The Department of Health and Social Care has issued the GPES Data for Consented Research Directions 2026, enabling secure access to GP records for participants who have already consented to take part in major research studies, including UK Biobank, Our Future Health and Genomics England. This addresses a long-standing gap…
Ben KempMarch 4, 2026
Ashley Dalton MP, Minister for Public Health and Prevention, has resigned from her role to undergo oral chemotherapy. The MP for West Lancashire was diagnosed for a second time with breast cancer prior to her appointment in February 2025. Longstanding Labour MP Sharon Hodgson, who first entered Parliament in 2005, has been named as Ms Dalton's successor. We would like…
Ben KempMarch 3, 2026
The Department for Business and Trade (DBT) is calling for expressions of interest from UK companies and organisations to exhibit with us on the UK pavilion at BIO International Convention in San Diego this June. From 22-25 June, top decision-makers from up to 80 countries will be in San Diego to attend this key biopharma event. With approximately 20,000 delegates from around…
Ben KempMarch 3, 2026
The Evaluating Medical Tests is a 3-day online course designed for researchers seeking to apply robust methods in diagnostic test evaluation. Learn how to evaluate test variability, test accuracy and clinical impact. Explore the role of tests in screening, monitoring and diagnosis and gain insights into study designs and patient pathways. This course includes sessions where key content, theory and…
Ben KempMarch 3, 2026
Advancing IVD with Environmental Insight and Control From research laboratories to manufacturing suites and quality-controlled storage, in-vitro diagnostics (IVD) depend on stable, well-understood environments. Key parameters such as airborne particles, volatile organic compounds (VOCs), carbon dioxide, temperature, humidity, and pressure can all influence product performance, reproducibility, and yield. As diagnostic technologies progress and regulatory expectations grow, so does the need…
Ben KempMarch 3, 2026